Warner Chilcott to limit DTC, rely more on reps

Share this article:
Warner Chilcott said it would “make much more limited use of DTC in support of our existing brands,” relying instead on reps to drive market share gains. In a Q2 results statement, the company said advertising and promotion expenses were down $12.1 million, or 54% for the quarter, compared to Q2 2007, mainly on a reduction in DTC. The firm continues to air TV ads for its Loestrin 24. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.